Augmentation of antibody responses by retinoic acid and costimulatory molecules

Seminars in Immunology

Volumn 21, Issue 1, 2009, Pages 42-50

  Ross, A Catharine ^a,b   Chen, Qiuyan ^a   Ma, Yifan ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Antibody; B cell; Costimulation; Differentiation; Polyriboinosinic acid:polyribocytidylic acid; Retinoic acid; T cell dependent antigen; T cell independent antigen; Toll like receptor

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; POLYINOSINIC ACID; RETINOIC ACID; TETANUS TOXOID; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; GENE CONTROL; GENETIC TRANSCRIPTION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MONOTHERAPY; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PLASMA CELL; RETINOL DEFICIENCY; REVIEW; SINGLE DRUG DOSE; VACCINATION; VITAMIN SUPPLEMENTATION; XEROPHTHALMIA;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTES; CELL DIFFERENTIATION; CYTIDINE DEAMINASE; CYTOKINES; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; KILLER CELLS, NATURAL; NATURAL KILLER T-CELLS; TRANSCRIPTION FACTORS; TRETINOIN; VITAMIN A;

EID: 56249118321     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2008.08.004     Document Type: Review

References (95)

1. WHO/UNICEF integration of vitamin A supplementation with immunization: policy and programme implication. In: Report of a meeting. New York: UNICEF; 1998. p. 1-7.
2. Beaton G.H., Martorell R., Aronson K.A., Edmonston B., McCabe G., Ross A.C., et al. Vitamin A supplementation and child morbidity and mortality in developing countries. Food Nutr Bull 15 (1994) 282-289
3. Fischer Walker C.L., and Black R.E. Micronutrients and diarrheal disease. Clin Inf Dis 45 (2007) S73-S77
4. Ross A.C., and Harrison E.H. Vitamin A: nutritional aspects of retinoids and carotenoids. In: Zempleni J., Rucker R.B., McCormick D.B., and Suttie J.W. (Eds). Handbook of vitamins (2007), Taylor & Francis Group, Boca Raton 1-40
5. Stephensen C.B. Vitamin A, infection, and immune function. Annu Rev Nutr 21 (2001) 167-192
6. Villamor E., and Fawzi W.W. Effects of vitamin A supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev 18 (2005) 446-464
7. Altucci L., Leibowitz M.D., Ogilvie K.M., de Lera A.R., and Gronemeyer H. RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov 6 (2007) 793-810
8. Bastien J., and Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328 (2004) 1-16
9. Bour G., Lalevee S., and Rochette-Egly C. Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors. Trends Cell Biol 17 (2007) 302-309
10. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 12 (1994) 991-1045
11. Janeway Jr. C.A., Goodnow C.C., and Medzhitov R. Danger-pathogen on the premises! Immunological tolerance. Curr Biol 6 (1996) 519-522
12. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5 (2004) 987-995
13. Ma Y., Chen Q., and Ross A.C. Retinoic acid and polyriboinosinic:polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1/type 2 cytokines and lymphocyte populations. J Immunol 174 (2005) 7961-7969
14. Ma Y., and Ross A.C. The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid. Proc Natl Acad Sci U S A 102 (2005) 13556-13561
15. Chen X., Esplin B.L., Garrett K.P., Welner R.S., Webb C.F., and Kincade P.W. Retinoids accelerate B lineage lymphoid differentiation. J Immunol 180 (2008) 138-145
16. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., and Song S.Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21 (2004) 527-538
17. Ross A.C. Vitamin A deficiency and retinoid repletion regulate the antibody response to bacterial antigens and the maintenance of natural killer cells. Clin Immunol Immunopathol 80 (1996) S63-S72
18. Semba R.D., Muhilal, Scott A.L., Natadisastra G., West Jr. K.P., and Sommer A. Effect of vitamin A supplementation on immunoglobulin G subclass responses to tetanus toxoid in children. Clin Diagn Lab Immunol 1 (1994) 172-175
19. Pasatiempo A.M., Kinoshita M., Foulke D.T., and Ross A.C. The antibody response of vitamin A-deficient rats to pneumococcal polysaccharide is enhanced through coimmunization with lipopolysaccharide. J Infect Dis 169 (1994) 441-444
20. Arora D., and Ross A.C. Antibody response against tetanus toxoid is enhanced by lipopolysaccharide or tumor necrosis factor-alpha in vitamin A-sufficient and -deficient rats. Am J Clin Nutr 59 (1994) 922-928
21. DeCicco K.L., Youngdahl J.D., and Ross A.C. All-trans-retinoic acid and polyriboinosinic: polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity. Immunology 104 (2001) 341-348
22. Marciani D.J. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today 8 (2003) 934-943
23. DeCicco K.L., Zolfaghari R., Li N., and Ross A.C. Retinoic acid and polyriboinosinic acid act synergistically to enhance the antibody response to tetanus toxoid during vitamin A deficiency: possible involvement of interleukin-2 receptor-beta, signal transducer and activator of transcription-1, and interferon regulatory factor-1. J Infect Dis 182 Suppl 1 (2000) S29-S36
24. Ertesvag A., Aasheim H.C., Naderi S., and Blomhoff H.K. Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK. Blood 109 (2007) 3865-3872
25. Semba R.D., Muhilal, Ward B.J., Griffin D.E., Scott A.L., Natadisastra G., et al. Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet 341 (1993) 5-8
26. Dawson H.D., and Ross A.C. Chronic marginal vitamin A status affects the distribution and function of T cells and natural T cells in aging Lewis rats. J Nutr 129 (1999) 1782-1790
27. Ross A.C. Retinoids and the immune system. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). THE RETINOIDS: biology, chemistry, and medicine. 2nd ed. (1994) 521-543
28. Hengesbach L.M., and Hoag K.A. Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice. J Nutr 134 (2004) 2653-2659
29. Geissmann F., Revy P., Brousse N., Lepelletier Y., Folli C., Durandy A., et al. Retinoids regulate survival and antigen presentation by immature dendritic cells. J Exp Med 198 (2003) 623-634
30. Manicassamy S., and Pulendran B. Retinoic acid dependent regulation of immune responses by dendritic cells and macrophages. Semin Immunol 21 (2009) 22-27
31. Iwata M. Retinoic acid production by intestinal dendritic cells and its role in T-Cell Trafficking. Semin Immunol 21 (2009) 8-13
32. Na S.Y., Kang B.Y., Chung S.W., Han S.J., Ma X., Trinchieri G., et al. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J Biol Chem 274 (1999) 7674-7680
33. Hoag K.A., Nashold F.E., Goverman J., and Hayes C.E. Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells. J Nutr 132 (2002) 3736-3739
34. Chen Q., Ma Y., and Ross A.C. Opposing cytokine-specific effects of all-trans-retinoic acid on the activation and expression of signal transducer and activator of transcription (STAT)-1 in THP-1 cells. Immunology 107 (2002) 199-208
35. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80 (1995) 707-718
36. Dawson H.D., and Ross A.C. Chronic marginal vitamin A status affects the distribution and function of T cells and natural T calls in aging Lewis rats. J Nutr 129 (1999) 1782-1790
37. Cantorna M.T., Nashold F.E., and Hayes C.E. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol 152 (1994) 1515-1522
38. DeCicco K.L., and Ross A.C. All-trans-retinoic acid and polyriboinosinoic:polyribocytidylic acid cooperate to elevate anti-tetanus immunoglobulin G and immunoglobulin M responses in vitamin A-deficient Lewis rats and Balb/c mice. Proc Nutr Soc 59 (2000) 519-529
39. Iwata M., Eshima Y., and Kagechika H. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol 15 (2003) 1017-1025
40. Nozaki Y., Yamagata T., Yoo B.S., Sugiyama M., Ikoma S., Kinoshita K., et al. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice. Clin Exp Immunol 139 (2005) 74-83
41. Austenaa L.M., and Ross A.C. Potentiation of interferon-gamma-stimulated nitric oxide production by retinoic acid in RAW 264.7 cells. J Leukoc Biol 70 (2001) 121-129
42. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 15 (1997) 323-350
43. Akira S., and Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85 (2003) 85-95
44. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001) 732-738
45. Avramidis N., Victoratos P., Yiangou M., and Hadjipetrou-Kourounakis L. Adjuvant regulation of cytokine profile and antibody isotype of immune responses to Mycoplasma agalactiae in mice. Vet Microbiol 88 (2002) 325-338
46. Manetti R., Annunziato F., Tomasevic L., Gianno V., Parronchi P., Romagnani S., et al. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur J Immunol 25 (1995) 2656-2660
47. Verdijk R.M., Mutis T., Esendam B., Kamp J., Melief C.J., Brand A., et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 163 (1999) 57-61
48. Lepe-Zuniga J.L., Rotbein J., and Gutterman J.U. Production of interferon-alpha induced by dsRNA in human peripheral blood mononuclear cell cultures: role of priming by dsRNA-induced interferons-gamma and -beta. J Interferon Res 9 (1989) 445-456
49. Huang Y.M., Adikari S., Bave U., Sanna A., and Alm G. Multiple sclerosis: interferon-beta induces CD123(+)BDCA2-dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production. J Neuroimmunol 158 (2005) 204-212
50. Cantorna M.T., Nashold F.E., Chun T.Y., and Hayes C.E. Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J Immunol 156 (1996) 2674-2679
51. Mora J.R., and von Andrian U.H. Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells. Semin Immunol 21 (2009) 28-35
52. Adkins B., Leclerc C., and Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 4 (2004) 553-564
53. Ross A.C. Introduction to vitamin A: a nutritional and life cycle perspective. In: Packer L., Obermüller-Jevic U., Kraemer K., and Sies H. (Eds). Carotenoids and retinoids. molecular aspects and health issues (2005), AOCS Press, Champaign, IL 23-41
54. Levin D., and Gershon H. Antigen presentation by neonatal murine spleen cells. Cell Immunol 120 (1989) 132-144
55. Muthukkumar S., Goldstein J., and Stein K.E. The ability of B cells and dendritic cells to present antigen increases during ontogeny. J Immunol 165 (2000) 4803-4813
56. Otero D.C., Anzelon A.N., and Rickert R.C. CD19 function in early and late B cell development. I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals. J Immunol 170 (2003) 73-83
57. Otero D.C., and Rickert R.C. CD19 function in early and late B cell development. II. CD19 facilitates the pro-B/pre-B transition. J Immunol 171 (2003) 5921-5930
58. Ertesvag A., Naderi S., and Blomhoff H.K. Regulation of B cell proliferation and differentiation by retinoic acid. Semin Immunol 21 (2009) 36-41
59. DeFranco A.L. B-cell activation 2000. Immunol Rev 176 (2000) 5-9
60. Bishop G.A., and Hostager B.S. Signaling by CD40 and its mimics in B cell activation. Immunol Res 24 (2001) 97-109
61. Lund F.E. Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity. Mol Med 12 (2006) 328-333
62. Gao Y., Camacho L.H., and Mehta K. Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-gamma/interleukin-1beta-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndrome. Leuk Res 31 (2007) 455-463
63. Morikawa K., and Nonaka M. All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturing into plasma cells. Int Immunopharmacol 5 (2005) 1830-1838
64. Ohtsuka Y., and Sanderson I.R. Transforming growth factor-beta: an important cytokine in the mucosal immune response. Curr Opin Gastroenterol 16 (2000) 541-545
65. Park J.Y., Yoon S.H., Kim E.K., Yun S.O., Park M.Y., Sohn H.J., et al. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells. Immunol Lett 116 (2008) 33-40
66. Moon B.G., Yoshida T., Shiiba M., Nakao K., Katsuki M., Takaki S., et al. Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells. Immunology 102 (2001) 289-300
67. Kuchen S., Robbins R., Sims G.P., Sheng C., Phillips T.M., Lipsky P.E., et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol 179 (2007) 5886-5896
68. Nera K.P., and Lassila O. Pax5-a critical inhibitor of plasma cell fate. Scand J Immunol 64 (2006) 190-199
69. Engedal N., Gjevik T., Blomhoff R., and Blomhoff H.K. All-trans retinoic acid stimulates IL-2-mediated proliferation of human T lymphocytes: early induction of cyclin D3. J Immunol 177 (2006) 2851-2861
70. Naderi S., and Blomhoff H.K. Retinoic acid prevents phosphorylation of pRB in normal human B lymphocytes: regulation of cyclin E, cyclin A, and p21(Cip1). Blood 94 (1999) 1348-1358
71. Guidoboni M., Zancai P., Cariati R., Rizzo S., Dal Col J., Pavan A., et al. Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. Cancer Res 65 (2005) 587-595
72. Chen Q., and Ross A.C. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. Proc Natl Acad Sci U S A 102 (2005) 14142-14149
73. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
74. Tokuyama H., and Tokuyama Y. The regulatory effects of all-trans-retinoic acid on isotype switching: retinoic acid induces IgA switch rearrangement in cooperation with IL-5 and inhibits IgG1 switching. Cell Immunol 192 (1999) 41-47
75. Tokuyama Y., and Tokuyama H. Retinoids as Ig isotype-switch modulators. The role of retinoids in directing isotype switching to IgA and IgG1 (IgE) in association with IL-4 and IL-5. Cell Immunol 170 (1996) 230-234
76. Lee C.G., Kinoshita K., Arudchandran A., Cerritelli S.M., Crouch R.J., and Honjo T. Quantitative regulation of class switch recombination by switch region transcription. J Exp Med 194 (2001) 365-374
77. Chen Q., and Ross A.C. Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4. Cell Immunol 249 (2007) 37-45
78. Xu M.Z., and Stavnezer J. Regulation of transcription of immunoglobulin germ-line gamma 1 RNA: analysis of the promoter/enhancer. EMBO J 11 (1992) 145-155
79. Cunningham K., Ackerly H., Alt F., and Dunnick W. Potential regulatory elements for germline transcription in or near murine Sgamma1. Int Immunol 10 (1998) 527-536
80. Lin S.C., and Stavnezer J. Activation of NF-kappaB/Rel by CD40 engagement induces the mouse germ line immunoglobulin Cgamma1 promoter. Mol Cell Biol 16 (1996) 4591-4603
81. Delphin S., and Stavnezer J. Regulation of antibody class switching to IgE: characterization of an IL-4-responsive region in the immunoglobulin heavy-chain germline epsilon promoter. Ann N Y Acad Sci 764 (1995) 123-135
82. Xu Z., Pone E.J., Al-Qahtani A., Park S.R., Zan H., and Casali P. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol 27 (2007) 367-397
83. Cattoretti G., Buttner M., Shaknovich R., Kremmer E., Alobeid B., and Niedobitek G. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 107 (2006) 3967-3975
84. Sayegh C.E., Quong M.W., Agata Y., and Murre C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 4 (2003) 586-593
85. Gonda H., Sugai M., Nambu Y., Katakai T., Agata Y., Mori K.J., et al. The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med 198 (2003) 1427-1437
86. Delogu A., Schebesta A., Sun Q., Aschenbrenner K., Perlot T., and Busslinger M. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24 (2006) 269-281
87. Shaffer A.L., Yu X., He Y., Boldrick J., Chan E.P., and Staudt L.M. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13 (2000) 199-212
88. Ye B.H., Cattoretti G., Shen Q., Zhang J., Hawe N., de Waard R., et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16 (1997) 161-170
89. Nera K.P., Kohonen P., Narvi E., Peippo A., Mustonen L., Terho P., et al. Loss of Pax5 promotes plasma cell differentiation. Immunity 24 (2006) 283-293
90. Calame K. Activation-dependent induction of Blimp-1. Curr Opin Immunol 20 (2008) 259-264
91. Shapiro-Shelef M., Lin K.I., McHeyzer-Williams L.J., Liao J., McHeyzer-Williams M.G., and Calame K. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19 (2003) 607-620
92. Shaffer A.L., Shapiro-Shelef M., Iwakoshi N.N., Lee A.H., Qian S.B., Zhao H., et al. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21 (2004) 81-93
93. Worm M., Krah J.M., Manz R.A., and Henz B.M. Retinoic acid inhibits CD40+ interleukin-4-mediated IgE production in vitro. Blood 92 (1998) 1713-1720
94. Scheffel F., Heine G., Henz B.M., and Worm M. Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production. Inflamm Res 54 (2005) 113-118
95. Worm M., Herz U., Krah J.M., Renz H., and Henz B.M. Effects of retinoids on in vitro and in vivo IgE production. Int Arch Allergy Immunol 124 (2001) 233-236